VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Journey Medical Corporation (DERM) Total Return Calculator with Dividends Reinvested

Journey Medical Corporation

Popular:

The total return for Journey Medical Corporation (DERM) stock is -19.85% over the past 12 months. So far it's down 30.07% this year. The 5-year total return is -45.16%, meaning $10,000 invested in DERM stock 5 years ago would be worth $5,484 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in DERM 1 year ago, it would be worth $7,496 today — you'd have lost $2,504.

With Dividends Reinvested$7,496-25.04%

Price Only (No DRIP)$7,496-25.04%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in DERM

1Y$8,015-$1,985 (-19.8%)-19.8% CAGR

3Y$31,576+$21,576 (+215.8%)46.7% CAGR

5Y$5,484-$4,516 (-45.2%)-11.3% CAGR

10Y$5,484-$4,516 (-45.2%)-5.8% CAGR

15Y$5,484-$4,516 (-45.2%)-3.9% CAGR

20Y$5,484-$4,516 (-45.2%)-3.0% CAGR

30Y$5,484-$4,516 (-45.2%)-2.0% CAGR

Journey Medical Corporation did not pay dividends during this period. Total return = price return.

Loading DERM total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-30.07%	—	-30.07%	—	$6,993
1Y	-19.85%	-19.85%	-19.85%	—	$8,015
3Y	+215.76%	46.71%	+215.76%	—	$31,576
5Y	-45.16%	-11.32%	-45.16%	—	$5,484
10Y	-45.16%	-5.83%	-45.16%	—	$5,484
15Y	-45.16%	-3.93%	-45.16%	—	$5,484
20Y	-45.16%	-2.96%	-45.16%	—	$5,484
30Y	-45.16%	-1.98%	-45.16%	—	$5,484

Risk & Highlights

Best Year+213.04%2023

Worst Year-63.88%2022

Max Drawdown-52.59%2026-01-22 → 2026-03-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+9.66%	+9.66%	—	+0.41%	+9.3pp
2025	+92.75%	+92.75%	—	+16.64%	+76.1pp
2024	-27.99%	-27.99%	—	+24.00%	-52.0pp
2023	+213.04%	+213.04%	—	+24.81%	+188.2pp
2022	-63.88%	-63.88%	—	-19.95%	-43.9pp

DERM underperformed the S&P 500 by 51.17pp over the past year (-19.85% vs +31.32%).

Loading summary...

DERM Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
DERMJourney Medical Corporation	$106M	+7.2%	-30.1%	-19.8%	—	+215.8%	-45.2%	-45.2%
SKINThe Beauty Health Company	$121M	+4.5%	-33.4%	-11.2%	—	-91.5%	-92.7%	-91.4%
PRGOPerrigo Company plc	$1.7B	+15.8%	-9.6%	-45.6%	+4.7pp	-56.6%	-58.6%	-76.8%
NVCRNovoCure Limited	$1.9B	+56.4%	+25.7%	+1.0%	—	-76.2%	-91.5%	+31.0%
PODDInsulet Corporation	$10.6B	-25.7%	-46.6%	-41.6%	—	-52.6%	-40.3%	+407.8%
VYNEVYNE Therapeutics Inc.	$29M	+8.4%	+15.4%	-50.4%	—	-92.3%	-99.0%	-100.0%
PCRXPacira BioSciences, Inc.	$932M	+6.4%	-3.1%	-5.8%	—	-43.9%	-62.5%	-50.0%
MCKMcKesson Corporation	$91.1B	-13.2%	-9.6%	+5.0%	+0.4pp	+104.0%	+308.4%	+351.9%
CAHCardinal Health, Inc.	$45.1B	-9.9%	-6.4%	+27.6%	+1.3pp	+134.8%	+256.4%	+174.5%
HSICHenry Schein, Inc.	$8.3B	-3.2%	-5.7%	+9.4%	—	-9.2%	-9.4%	+8.7%
ACRSAclaris Therapeutics, Inc.	$576M	+25.8%	+66.0%	+273.4%	—	-43.1%	-79.9%	-76.9%

Compare:DERM vs SKIN DERM vs PRGO DERM vs NVCR DERM vs SKIN vs PRGO

About DERM Dividend Returns

Journey Medical Corporation (DERM) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of DERM over the past year?

Journey Medical Corporation (DERM) delivered a return of -19.85% over the past year. Since DERM does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in DERM be worth today?

A $10,000 investment in Journey Medical Corporation one year ago would be worth $8,015 today, representing a loss of $1,985.

Q3Does DERM pay dividends?

Journey Medical Corporation (DERM) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For DERM, the total return equals the price-only return.

Q4Did DERM beat the S&P 500?

No, Journey Medical Corporation (DERM) underperformed the S&P 500 by 51.17 percentage points over the past year. DERM delivered a total return of -19.85%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed DERM by 51.17pp during this period.

Q5What is DERM's worst drawdown?

Journey Medical Corporation (DERM) experienced a maximum drawdown of -52.59% over the past year, declining from its peak on 2026-01-22 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is DERM's long-term total return over 10, 20, or 30 years?

Here are Journey Medical Corporation (DERM)'s long-term returns with dividends reinvested. Over 10 years, the total return is -45.2% (-5.8% CAGR) — $10,000 would have grown to $5,484. Over 20 years: -45.2% total return (-3.0% CAGR) — $10,000 → $5,484. Over 30 years: -45.2% total return (-2.0% CAGR) — $10,000 → $5,484. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was DERM's best and worst year?

Journey Medical Corporation's best calendar year was 2023 with a total return of 213.0%. Its worst year was 2022 with a total return of -63.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 276.9 percentage points.